ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

Richter receives marketing authorisation for Libdree in UK

Hungary Richter Q2 results beat expectations

Vraylar sales skyrockets, revenue rises

EU signs deal with Gilead to supply COVID-19 drug

EUR 63 mn for 30,000 doses of remdesivir

ANALYST VIEW - Jefferies reviews Richter 'wonder' drug

Vraylar sequential growth to continue after lockdown

EU approves Covid-19 drug remdesivir

Gilead’s Veklury first to get go-ahead

ANALYST VIEW - J.P. Morgan cuts target price for Hungary's Richter

Rating is overweight

ANALYST VIEW - Jefferies publishes research on Hungary's Richter

Target price, rating remain unchanged

Richter to pay HUF 63 dividend per share

Hungary Richter lowers 2020 sales target

It revises EBIT forecast upwardly, though

Hungary Richter posts record revenue in Q1 2020

Exceeds profit expectations

Hungary Richter expected to report sales close to previous record

First quarter turned out well, according to analysts

Hungary's Richter signs contract manufacturing deal for COVID-19 vaccine

Richter-Helm joint venture to produce Inovio's DNA vaccine

Richter buys antirheumatic drug from Mycenax

In USD 16.5 mn deal

Hungary Richter reveals response to COVID-19 pandemic

Measures introduced to protect employees and to reduce risk of any potential contagion

Hungary Richter to pay HUF 63 dividend per share

According to draft resolutions for general meeting

ANALYST VIEW - Jefferies expects market to 'like' Richter deal

Endorses spending of Vraylar cash

Hungary's Richter adds new product to gynaecological portfolio

For treatment of uterine fibroids and endometriosis

Hungary Richter to launch 'wonderdrug' on new market

Company signs exclusive license and supply agreement

EMA accepts new Richter contraceptive

To be sold in Europe and Russia